EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dapagliflozin Restores NRF2-Associated Antioxidant Signaling and Mitochondrial Maintenance Markers in Doxorubicin-Challenged H9C2 Cardiomyoblasts: An In Vitro Mechanistic Study

Moran Dong, Yaoyao Wang, Liyan Wan

Acta Poloniae Pharmaceutica - Drug Research · 27.07.2026 · 84 (2) · 219-237

DOI: 10.32383/appdr/224826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 27.07.2026. Verfasst von Moran Dong und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX) is an effective anticancer agent, but its clinical use is limited by cardiotoxicity involving oxidative stress, mitochondrial dysfunction, energetic depletion, and apoptosis. This study investigated whether dapagliflozin (DAPA) protects H9c2 cardiomyoblasts against DOX-induced injury through restoration of Nrf2-associated antioxidant signaling, mitochondrial-maintenance markers, and anti-apoptotic balance. H9c2 cells were assigned to Control, DAPA, DOX, and DOX plus DAPA groups. Cell viability, ROS accumulation, MDA levels, ATP content, and morphology were assessed using MTT assay, DCFDA staining, MDA assay, ATP assay, and bright-field microscopy. Antioxidant, mitochondrial-maintenance, and apoptosis-related markers were examined by RT-qPCR and Western blotting. Nrf2 localization was evaluated by nuclear/cytoplasmic fractionation, and Nrf2 occupancy at antioxidant regulatory loci was assessed by ChIP-qPCR. DOX reduced cell viability, increased ROS and MDA levels, depleted ATP content, disrupted morphology, impaired Nrf2 nuclear localization, suppressed antioxidant and mitochondrial-maintenance markers, reduced Nrf2 occupancy at Hmox1 and Nqo1 regulatory regions, and induced an apoptosis-associated profile. In contrast, DAPA reduced oxidative injury, partially restored ATP content and morphology, increased Nfe2l2, Hmox1, Nqo1, Ppargc1a, Nrf1, and Tfam mRNA expression, restored Nrf2 nuclear localization, recovered Nrf2 enrichment at Hmox1 and Nqo1 regulatory regions, and attenuated Bax/caspase-3/PARP-associated apoptotic signaling. These findings indicate that DAPA protects DOX-challenged H9c2 cardiomyoblasts in association with restored Nrf2 regulatory engagement, partial recovery of energetic and mitochondrial-maintenance markers, and attenuation of apoptosis-associated signaling.

Zitieren

APA

Dong, M., Wang, Y., & Wan, L. (2026). Dapagliflozin Restores NRF2-Associated Antioxidant Signaling and Mitochondrial Maintenance Markers in Doxorubicin-Challenged H9C2 Cardiomyoblasts: An In Vitro Mechanistic Study. Acta Poloniae Pharmaceutica - Drug Research, 84(2), 219-237. https://doi.org/10.32383/appdr/224826

Vancouver

Dong M, Wang Y, Wan L. Dapagliflozin Restores NRF2-Associated Antioxidant Signaling and Mitochondrial Maintenance Markers in Doxorubicin-Challenged H9C2 Cardiomyoblasts: An In Vitro Mechanistic Study. Acta Poloniae Pharmaceutica - Drug Research. 2026;84(2):219-237. doi:10.32383/appdr/224826

BibTeX
@article{Dong2026,
  author = {Dong, Moran and Wang, Yaoyao and Wan, Liyan},
  title = {Dapagliflozin Restores NRF2-Associated Antioxidant Signaling and Mitochondrial Maintenance Markers in Doxorubicin-Challenged H9C2 Cardiomyoblasts: An In Vitro Mechanistic Study},
  journal = {Acta Poloniae Pharmaceutica - Drug Research},
  year = {2026},
  volume = {84},
  number = {2},
  pages = {219--237},
  doi = {10.32383/appdr/224826}
}
Kostenlos starten →